INSIGHTS ON DRUG DEVELOPMENT
-
What Is DMPK, And Why Does It Matter In Drug Development?
By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.
-
The Role Of CRISPR Cas9 Plasmids In Gene-Editing
Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.
-
Developing High Concentration Biopharmaceuticals: Formulation Considerations
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and presents case studies on how composition changes during the concentration process can be effectively characterized.
-
Rapid, Automated, At-Line Adenovirus Quantitation
Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.
-
Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development7/9/2025
Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.
-
Solid State Hydrogen Deuterium Exchange To Study Antibody Drug Conjugate Stability10/16/2024
Discover how this solid-state HDX-MS is being used to revolutionize the prediction of stability for IgG-based Antibody Drug Conjugates and enhance ADC development processes.
-
A New Framework For Identifying Nitrosamine Risks And Derisking Products6/18/2024
Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.
-
A Comparative Efficiency Analysis Of Commercial Transfection Reagents In HEK 293 Cells3/27/2025
This study presents a detailed comparative analysis of the efficiency, viability, and cytotoxic effects of four widely used transfection reagents on Human Embryonic Kidney 293 (HEK293) cells.
-
Modular Facilities With Smaller Footprint Through Dynamic Perfusion6/30/2025
Discover how a top CDMO leveraged dynamic perfusion technology to boost biomanufacturing throughput, cut capital costs, and enable flexible, multi-modality production.
DRUG DEVELOPMENT SOLUTIONS
-
An industry-renowned instrument for monitoring GPCRs and ion channels
Powered by a new, optional high-speed EMCCD camera and the new Peak Pro 2 software module, the new FLIPR® Penta High-Throughput Cellular Screening System allows you to measure and analyze peaks of human-derived induced pluripotent stem cells (hiPSCs), differentiated into cardiomyocytes and neurons, up to 100 times per second and quickly cherry pick events such as Early Afterdepolarization-like events (EAD-like events), fibrillation, and irregular beating.
-
Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.
-
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
With deep expertise and state-of-the-art infrastructure, Aragen partners with pharmaceutical companies, biotechnology innovators, and academic institutions to accelerate discovery and bring forward impactful therapies.
-
These patented synthesis columns offer oligonucleotide manufacturers a system designed for efficiency and safety.